3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Gastrointestinal
16
Thoracic
8
Breast
5
Head & Neck
4
Lymphoid
3
Other hematologic neoplasm
2
Gynecologic
2
Genitourinary
2
Sarcoma
1
Myeloid
1
Classical hematology
1
Conditions
Lymphoma
539
Precursor Cell Lymphoblastic Leukemia-Lymphoma
499
Lymphoma, Non-Hodgkin
435
Lymphoma, Follicular
403
Leukemia, Lymphocytic, Chronic, B-Cell
388
Lymphoma, Large B-Cell, Diffuse
385
Lymphoma, B-Cell
246
Lymphoma, Mantle-Cell
222
Hodgkin Disease
207
Recurrence
204
Leukemia, Myeloid, Acute
197
Leukemia
191
Multiple Myeloma
184
Burkitt Lymphoma
181
Lymphoma, B-Cell, Marginal Zone
170
Neoplasms
151
Myelodysplastic Syndromes
132
Hematologic Neoplasms
115
Waldenstrom Macroglobulinemia
103
Lymphoma, T-Cell, Peripheral
85
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
81
Lymphoma, T-Cell
81
Lymphoma, T-Cell, Cutaneous
66
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
62
Mycosis Fungoides
57
Leukemia, Biphenotypic, Acute
54
Breast Neoplasms
54
Myeloproliferative Disorders
50
Leukemia, B-Cell
50
Lymphoproliferative Disorders
47
Interventions
nicotinamide-beta-riboside
1
Wearable Electronic Devices
1
Resistance Training
1
Exercise
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Sarcopenia
×
Lymphoid
×
1 year
×
Clear all
NCT07325305
2026-04-13
PROTECT
Murdoch Childrens Research Institute
Phase NA
Recruiting
60 enrolled
NCT05556239
2025-12-08
STAY-STRONG
Rigshospitalet, Denmark
Phase NA
Completed
42 enrolled
NCT05194397
2025-12-04
IAMFIT
Children's Hospital of Philadelphia
Phase 2
Recruiting
80 enrolled